Abstract
Adult respiratory distress syndrome (ARDS) [1] is not a disease but a disorder which is associated with many clinical states, the most frequent being sepsis, trauma, and aspiration of gastric contents [19]. Less frequently occurring situations are amniotic fluid embolization, acute pancreatitis, radiation lung injury, disseminated intravascular coagulation, and ARDS induced by certain drugs [13]. ARDS was described approximately 20 years ago, yet, since its description the overall mortality has remained stable, indicating that, although some aspects of this syndrome have been studied in various model systems [4–8, 11, 14, 15], the impact of these experiments on patient survival has been very small [2]. Conceptually, ARDS is a massive insult damaging the integrity of the lung membranes. The event which triggers a cascade of metabolic reactions is acute; occasionally the syndrome is rather transient, but most frequently the lung subsequently undergoes a chronic inflammatory phase which leads to cell proliferation and scar tissue formation [19]. The lung circulation is involved in the syndrome since the injurious agents, for example lipopolysaccharide or activated circulating cells, are often carried to the lung via the bloodstream. Pulmonary hypertension has been recognized as part of the syndrome in many patients, as described by Zapol and Snider in 1977 [20]. Morphological studies show obliteration of pulmonary arteries, perivascular edema, and compression of the microcirculation by edema fluid.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Asbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2:319–323
Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman KK, Higgins S, Bradley R, Metz CA, Harris TR, Brigham KL (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565–1570
Bussolino F, Camussi G, Baglioni C (1988) Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin I. J Biol Chem 263:11856–11861
Chang S, Voelkel NF (1989) Charge related lung microvascular injury (state of the art). Am Rev Respir Dis 139:534–545
Chang S, Feddersen CO, Henson PM, Voelkel NF (1987) Platelet activating factor mediates hemodynamic changes and lung injury in endotoxin treated rats. J Clin Invest 79:1498–1509
Chang S, Westcott JY, Pickett WC, Murphy RC, Voelkel NF (1989) Endotoxin-induced lung injury in the rat: the role of eicosanoids. J Appl Physiol 66:2407–2418
Chang S, Czartolomna J, Voelkel NF (1990) Role of eicosanoids in staphylococcal α-toxin induced lung injury in the rat. J Appl Physiol (to be published)
Chang S, Fernyak S, Voelkel NF (1990) Post-treatment with WEB 2086, a platelet activating factor antagonist, decreases lung injury in endotoxin-treated rats. Am J Physiol 258 153–158, 1990
Garrett RC, Thomas HM III (1983) Meclofenamate uniformly decreases shunt fraction in dogs with lobar atelectasis. J Appl Physiol 54:284–289
Graham LM, Vasil A, Vasil ML, Voelkel NF, Stenmark KR (1990) Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. Am Rev Resp Dis 142, 221–229, 1990
Hanley PJ, Sienko A, Light RB (1988) Role of prostacyclin and thromboxane in the circulatory changes of acute bacteremic Pseudomonas pneumonia in dogs. Am Rev Respir Dis 137:700–706
Lewis MS, Whatley RE, Cain P (1988) Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial-cell dependent neutrophil adhesion. J Clin Invest 82:2045–2055
McDonnell TJ, Voelkel NF, Petty TL (1987) Adult respiratory distress syndrome and its management. Comprehensive Therapy 13(7):33–40
McDonnell TJ, Chang SW, Westcott JY, Voelkel NF (1988) Role of oxidants, eicosanoids, and neutrophils in amphotericin B lung injury in rats. J Appl Physiol 65(5): 2195–2206
Newman JH, Loyd JE, English DK, Ogletree ML, Fulkerson WJ, Brigham KL (1983) Effects of 100% oxygen on lung vascular function in awake sheep. J Appl Physiol 54:1379–1368
Prescott CM, Zimmerman GA, McIntyre TM (1987) The production of platelet-activating factor by cultured human endothelial cells: regulation and function. In: Snyder F (ed) Platelet -activating factor and related lipid mediators. Plenum, New York, pp 323–340
Sakai A, Chang S, Voelkel NF (1989) The importance of vasoconstriction in lipid mediator induced pulmonary edema. J Appl Physiol 66, 2667–2674, 1989
Van Grondelle A, Worthen GS, Ellis D et al. (1984) Altering hydrodynamic variables influences PGI2 production by isolated lungs and endothelial cells. J Appl Physiol 57:388–395
Voelkel NF (1990) The adult respiratory distress syndrome. Klin Wochenschr 67, 559–567, 1989
Zapol W, Snider G (1977) Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 296:476–480
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Voelkel, N.F., Chang, S., McDonnell, T., Chen, C., Czartolomna, J. (1992). Regulation of the Pulmonary Circulation During Lung Injury. In: Rügheimer, E. (eds) New Aspects on Respiratory Failure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74943-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-74943-8_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74945-2
Online ISBN: 978-3-642-74943-8
eBook Packages: Springer Book Archive